Literature DB >> 22721930

Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.

Viviane Gnemmi1, Xavier Leleu, François Provot, Florence Moulonguet, David Buob.   

Abstract

Waldenström macroglobulinemia is a rare low-grade hematologic malignancy due to clonal proliferation of B lymphocytes responsible for immunoglobulin M (IgM) monoclonal gammopathy secreted in serum. This disease is characterized by lymphoplasmacytic tumoral infiltration of bone marrow and various organs, especially the liver and spleen. Kidney involvement in Waldenström macroglobulinemia has been described previously with reports of various forms of glomerular injury: large intracapillary IgM pseudothrombi, cryoglobulinemia-associated membranoproliferative glomerulonephritis, or amyloidosis. Interstitial infiltration by tumoral B lymphocytes is another classic pattern. Conversely, tubular involvement in the form of myeloma-like casts or basement membrane deposition of monoclonal light chain (light-chain deposition disease) is unusual. We report the occurrence of cast nephropathy associated with light-chain deposition disease in 2 patients with Waldenström macroglobulinemia, which resulted in severe and prolonged kidney failure.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22721930     DOI: 10.1053/j.ajkd.2012.01.030

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

2.  Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis.

Authors:  Jean-Baptiste Gibier; Viviane Gnemmi; François Glowacki; Eileen M Boyle; Benjamin Lopez; Evelyne MacNamara; Maxime Hoffmann; Raymond Azar; Thomas Guincestre; Franck Bourdon; Marie-Christine Copin; David Buob
Journal:  Mod Pathol       Date:  2017-10-20       Impact factor: 7.842

3.  Cast nephropathy: an extremely rare renal presentation of Waldenström's macroglobulinaemia.

Authors:  Tânia Santos; Susana Machado; Vítor Sousa; Mário Campos
Journal:  BMJ Case Rep       Date:  2015-10-07

4.  Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia.

Authors:  Jorge J Castillo; Ramon Garcia-Sanz; Evdoxia Hatjiharissi; Robert A Kyle; Xavier Leleu; Mary McMaster; Giampaolo Merlini; Monique C Minnema; Enrica Morra; Roger G Owen; Stephanie Poulain; Marvin J Stone; Constantine Tam; Marzia Varettoni; Meletios A Dimopoulos; Steven P Treon; Efstathios Kastritis
Journal:  Br J Haematol       Date:  2016-07-05       Impact factor: 6.998

5.  Thrombotic microangiopathy with intraglomerular IgM pseudothrombi in Waldenström macroglobulinemia and IgM monoclonal gammopathy.

Authors:  Serena Yen Shan Tan; Richard Kent Sibley; Sharina Belani; Sumie Iwasaki; Leonid Yankulin; Tracy Jonelis; John Patrick Twistington Higgins; Neeraja Kambham; Megan Leigh Troxell
Journal:  J Nephrol       Date:  2018-10-17       Impact factor: 3.902

Review 6.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09

7.  Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma Associated with Nephrotic Syndrome during Hemodialysis, Treated Successfully with Tirabrutinib.

Authors:  Yasunobu Sekiguchi; You Nishimura; Hiroaki Kanda; Machiko Kawamura; Kazuhiko Kobayashi; Hirofumi Kobayashi
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.